Abstract:
The present invention is directed to novel methods for enhancing the ability to separate a species of interest from other different species present in a free solution mixture thereof which takes advantage of interactions that occur between soluble, small molecular weight ligands and the species of interest. The small molecular weight ligands employed in the present invention function to interact with a species of interest in a mixture of different species through either affinity, hydrophobic and/or ionic interactions, thereby altering the molecular weight, hydrodynamic volume and/or isoelectric point of the species of interest and rendering it separable from other component(s) in the mixture.
Abstract:
Sample displacement chromatography is performed at low operating pressures (less than 30 bar) and/or at high sample loading (in excess of 500 mg/cm2 column area), with product recovery being effected in a non-gradient manner. The low operating pressures permit the use of simple and inexpensive apparatus. Non-gradient product recovery allows the desired product to be allowed in solutions with advantageously high concentration. Materials which may be purified include pharmaceuticals, pharmaceutical excipients, fine chemicals, biochemicals, X-ray contrast agents, chelating agents, peptides, proteins, oligonucleotides and vaccines. Apparatus embodiments include sample displacement chromatography apparatus comprising one or more ion exchange columns in direct combination with one or more desalting columns, and multicolumn chromatography apparatus permitting switching between a series separation mode and a parallel extraction mode.
Abstract:
Sample displacement chromatography is performed at low operating pressures (less than 30 bar) and/or at high sample loading (in excess of 500 mg/cm column area), with product recovery being effected in a non-gradient manner. The low operating pressures permit the use of simple and inexpensive apparatus. Non-gradient product recovery allows the desired product to be allowed in solutions with advantageously high concentration. Materials which may be purified include pharmaceuticals, pharmaceutical excipients, fine chemicals, biochemicals, X-ray contrast agents, chelating agents, peptides, proteins, oligonucleotides and vaccines. Apparatus embodiments include sample displacement chromatography apparatus comprising one or more ion exchange columns in direct combination with one or more desalting columns, and multicolumn chromatography apparatus permitting switching between a series separation mode and a parallel extraction mode.
Abstract translation:在低操作压力(小于30巴)和/或高样品负载(超过500mg / cm 2柱面积)下进行样品置换色谱,产物回收以非梯度方式进行。 低操作压力允许使用简单且便宜的装置。 非梯度产物回收允许所需产物在有利地高浓度的溶液中被允许。 可以纯化的材料包括药物,药物赋形剂,精细化学品,生物化学品,X射线造影剂,螯合剂,肽,蛋白质,寡核苷酸和疫苗。 装置实施方案包括样品置换色谱装置,其包括与一个或多个脱盐塔直接组合的一个或多个离子交换柱,以及允许在串联分离模式和并行提取模式之间切换的多色谱色谱装置。
Abstract:
An improved process for purifying a polypeptide with a packing for high-performance liquid chromatography, which comprises preteating polypeptides produced by various cells into a given state, adjusting the pH of an aqueous solution of the polypeptides to fall within a specified range to thereby remove contaminants by precipitation, and treating the remaining solution with a packing for reversed-phase high-performance liquid chromatography.
Abstract:
A carrier for column chromatography and its applications. The carrier is characterized by comprising a pectic acid-cellulose gel. When it is used for ion exchange chromatography and gel filtration chromatography, a water-soluble polymeric substance, particularly protein, is stably separated and purified, so that the recovery can be improved. Further, the removal of structural protein and cell wall-binding protein in the pectic acid-cellulose gel serves to reduce a non specific adsorption by remaining proteins.
Abstract:
A method of manufacturing oxytocin or oxytocin receptor agonist comprising a step of combining an antisolvent with a solution comprising oxytocin or oxytocin receptor agonist so as to precipitate a product oxytocin or a product oxytocin receptor agonist from the solution.
Abstract:
Methods of producing multiple protein products from blood-based materials including alpha-1-proteinase inhibitor, gamma globulin, albumin, and other proteins are described herein. The inventive methods include steps of: salt fractionation, chromatography, ultrafiltration, diafiltration, solvent-detergent treatment, and sterile filtration. Advantageously, the inventive methods are simple and produce alpha-1-proteinase inhibitor, gamma globulin, albumin, and other proteins in high yields. The sequence of process steps can be selected to obtain multiple products from various in-process materials, such as supernatants, pastes, chromatography flow-though, and chromatography washes.
Abstract:
公开了一种多肽化合物及其制备方法与应用,该多肽化合物结构式为:(X A X B X C X D X E -X) 2 KY,或{(X A X B X C X D X E -X) 2 K} 2 KY,或{({X A X B X C X D X E -X} 2 K) 2 K} 2 KY;其中:X A 为极性氨基酸分子,X B 和X E 为碱性氨基酸分子(可相同也可不相同),X C 和X D 为非极性氨基酸分子(可相同也可不相同),K为赖氨酸(Lys,K),X和Y为空或任意一个或多个氨基酸或化学基团。所述多肽化合物具有增强免疫的作用。